Featured Research

from universities, journals, and other organizations

Medical and financial impact of drug-related poisonings treated in US emergency departments

Date:
March 1, 2011
Source:
Nationwide Children's Hospital
Summary:
A new study examined emergency department (ED) visits for drug-related poisonings and found that in just one year (2007) in the US, there were approximately 700,000 ED visits costing nearly $1.4 billion in ED charges alone. This equates to an average of 1,900 drug-related ED visits and $3.8 million in ED charges each and every day in this country.

Dr. Gary Smith explains that his findings reinforce the importance of increasing efforts to prevent unintentional drug exposures among young children in the United States.
Credit: Nationwide Children's Hospital

Over the past decade, drug-related poisonings have been on the rise in the United States. In fact, in many states drug-related poisoning deaths have now surpassed motor vehicle crash fatalities to become the leading cause of injury death. While the fatalities from this epidemic have been well reported, they are only the tip of the iceberg.

A new study by researchers at the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital examined emergency department (ED) visits for drug-related poisonings and found that in just one year (2007) in the U.S., there were approximately 700,000 ED visits costing nearly $1.4 billion in ED charges alone. This equates to an average of 1,900 drug-related ED visits and $3.8 million in ED charges each and every day in this country.

"The magnitude of these findings is staggering," said Gary Smith, MD, DrPH, senior author of the study and director of the Center for Injury Research and Policy at Nationwide Children's Hospital. "The number and cost of drug-related poisonings identified in this study indicate a public health emergency that requires a decisive and coordinated response at national, state and local levels."

According to the study, appearing in the March 2011 issue of the American Journal of Emergency Medicine, poisoning by antidepressants and tranquilizers (24 percent) and poisoning by pain and fever control medicines (23 percent) were responsible for almost half of ED visits for drug-related poisoning. Among cases involving antidepressants and tranquilizers, 52 percent were suicidal poisonings and 30 percent were unintentional poisonings. In comparison, 41 percent of poisonings by pain and fever control medicines were suicidal and 40 percent were unintentional.

"The current epidemic of drug-related poisonings has a new face," said Dr. Smith, also a Professor of Pediatrics at The Ohio State University College of Medicine. "Unlike epidemics in the past involving illegal drugs, such as heroin and crack cocaine, misuse of prescription drugs, especially opioid pain medications, is now the cause of an unprecedented number of emergency department visits and deaths. Our study also demonstrated that the rate of ED visits for drug-related poisoning is three times higher in rural areas than in non-rural areas."

Also of concern was the study's finding that children 5 years and younger had a higher rate of ED visits for unintentional drug-related poisonings than all other age groups.

"Despite the fact that successful prevention strategies targeted at young children have helped to decrease the occurrence of drug-related poisonings in this population, the number of unintentional poisonings among this age group is still too high," said Dr. Smith. "Our findings reinforce the importance of increasing efforts to prevent unintentional drug exposures among young children in the United States."

Data for this study were obtained from the 2007 Nationwide Emergency Department Sample (NEDS), one of the Health Care Utilization Project data sets from the Agency for Healthcare Research and Quality. NEDS data enable analyses of ED utilization patterns and yield national estimates of ED visits. The 2007 NEDS was released in April 2010. The data set includes approximately 27 million ED visits from about 970 hospital-based EDs in 27 states, and it generates national estimates pertaining to more than 120 million ED visits.


Story Source:

The above story is based on materials provided by Nationwide Children's Hospital. Note: Materials may be edited for content and length.


Cite This Page:

Nationwide Children's Hospital. "Medical and financial impact of drug-related poisonings treated in US emergency departments." ScienceDaily. ScienceDaily, 1 March 2011. <www.sciencedaily.com/releases/2011/03/110301122144.htm>.
Nationwide Children's Hospital. (2011, March 1). Medical and financial impact of drug-related poisonings treated in US emergency departments. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/03/110301122144.htm
Nationwide Children's Hospital. "Medical and financial impact of drug-related poisonings treated in US emergency departments." ScienceDaily. www.sciencedaily.com/releases/2011/03/110301122144.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins